CLU and Alzheimer disease: CLU (clusterin), also called APOJ, is one of the earliest-discovered and strongest genetic risk factors for late-onset AD and has been proposed to affect AD risk by regulating diverse cellular processes including lipid transport, innate immunity, apoptosis, oxidative and proteostatic stress responses, and even copper homeostasis [45].